Why the study?
While some studies suggest eating disorders inherently cause QTc prolongation, emerging evidence suggests extrinsic factors may play a greater role.
Does the use of QTc-prolonging medications and electrolyte abnormalities increase QTc interval length in pediatric patients with eating disorders?
Does the use of QTc-prolonging medications and electrolyte abnormalities increase QTc interval length in pediatric patients with eating disorders?
In pediatric patients with eating disorders, QTc prolongation is significantly associated with extrinsic factors such as QTc-prolonging medications and electrolyte abnormalities, suggesting these are key modifiable risk factors to monitor.
QTc-prolonging medications were associated with longer QTc in pediatric eating disorder patients; leaves open electrolyte effects and needs prospective confirmation.
Introduction Eating disorders in pediatric populations are associated with several cardiac complications, including QTc prolongation, which can lead to fatal arrhythmias. While some studies suggest eating disorders inherently lead to QTc prolongation, emerging evidence suggests extrinsic factors may play a greater role. Methods This retrospective chart review evaluates QTc interval prolongation in pediatric patients with eating disorders at a tertiary children's hospital. Demographic factors, ECGs, electrolyte levels, and the use of QTc-prolonging medications were analyzed to evaluate their association with QTc prolongation. Results Among 435 patients, 405 had normal QTc intervals (<440 ms), 8 were borderline prolonged (440–460 ms), and 22 had prolonged intervals (>460 ms) using the Bazett calculation. Mean QTc values differed significantly across eating disorder subtypes ( p = 0.0063), with the longest values observed in bulimia nervosa and binge eating disorder, and the shortest in anorexia nervosa. Patients taking one or more QTc-prolonging medications had a longer mean QTc interval than those not taking medications ( p < 0.001). There were significant inverse correlations between serum calcium ( p = 0.0001), magnesium ( p = 0.01), and potassium ( p = 0.003) levels and QTc length. Discussion These findings suggest QTc-prolonging medications and electrolyte abnormalities can be associated with longer QTc intervals in pediatric patients with eating disorders and should continue to be monitored as modifiable risk factors.
No takes yet. Share an insight, caveat, or question.
Kacer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: